Healthcare -
Biotechnology - NASDAQ - US
$ 6.14
0.656 %
$ 520 M
Market Cap
-2.5
P/E
VERV - OTHER CURRENT LIABILITIES
Other Current Liabilities VERV - Verve Therapeutics, Inc.
20.2 M
LAST VALUE
35.21%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR